Today: 2 May 2026

Broadcom stock drops as chip ETFs rise; traders parse CES AI cues and Friday jobs report

Broadcom stock drops as chip ETFs rise; traders parse CES AI cues and Friday jobs report

Broadcom shares fell 2% to $340.71 Monday, underperforming chip ETFs that closed higher. The stock swung from an early high near $355 to a low around $336. Investors watched CES headlines and weak U.S. factory data for signals on AI demand and rates. Broadcom’s next earnings are due in early March; the U.S. jobs report arrives Friday.
5 January 2026
······
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech shares dropped 4.7% to $20.49 Monday, hitting a 52-week low and leaving the stock down 55% from its high. The decline comes ahead of the J.P. Morgan Healthcare Conference, where CEO Ying Huang is set to present Jan. 14. Broader biotech stocks also fell, with key ETFs down about 1%. Investors are watching for updates on CARVYKTI, Legend’s CAR-T therapy for multiple myeloma.
5 January 2026
·
Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina shares fell 5.1% to $151.12 Monday after an early rally above $165 faded, underperforming as Wall Street hit record highs. Electronics manufacturing peers Jabil, Flex, and Celestica also dropped, pressured by weak U.S. manufacturing data and Jabil’s acquisition of Hanley Energy. Investors are awaiting Friday’s U.S. jobs report and Sanmina’s upcoming earnings window.
5 January 2026
·
KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corp shares jumped 6.4% to $1,356 Monday, nearing a record close as chip-equipment stocks rallied ahead of CES and Nvidia CEO Jensen Huang’s keynote. The Philadelphia Semiconductor Index rose about 1%. Foxconn reported record Q4 revenue, citing AI demand. KLA last forecast Q2 revenue of about $3.225 billion and warned of risks from U.S. export rules affecting China sales.
5 January 2026
···
Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

Chevron shares jumped 5.5% to $164.52 after U.S. officials signaled support for American oil firms aiding Venezuela’s industry. The stock move followed weekend policy headlines and plans for meetings between the Trump administration and oil executives. Chevron, the only U.S. major still operating in Venezuela under a waiver, exports about 150,000 barrels per day to the Gulf Coast. The company reports earnings January 30.
5 January 2026
·
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

General Motors, Southwest Airlines, and Tapestry posted buyback yields above 10% after repurchasing $8.2 billion, $2.75 billion, and $2.8 billion in stock in 2025, MarketBeat reported Monday. S&P 500 companies bought back a record $1.02 trillion of stock in the 12 months through September, according to S&P Dow Jones Indices. Investors are watching if companies can sustain repurchases without hurting investment.
5 January 2026
···
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum Holdings shares dropped 7.6% to $356.69 Monday afternoon, leading declines among optical networking stocks as Coherent, Ciena, and Applied Optoelectronics also fell. The selloff followed a sharp rally that brought Lumentum near its December peak, with trading volume at 4.9 million shares by 3:24 p.m. EST. Investors are watching upcoming earnings and industry events for signs of continued AI-driven demand.
5 January 2026
·····
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma shares fell about 5% to $33.42 in afternoon trading Monday after two insiders filed Form 144 notices for proposed stock sales tied to RSU vesting. CFO M. Ian Somaiya and CSO Johannes Kastelein flagged plans to sell a combined 11,118 shares. The stock touched an intraday low of $32.68. Biotech stocks broadly lagged the market ahead of Friday’s U.S. jobs report.
5 January 2026
·
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Xenon Pharmaceuticals shares fell 6.5% to $41.60 Monday afternoon, underperforming biotech peers ahead of next week’s J.P. Morgan Healthcare Conference. The stock traded between $45.21 and $41.45 on volume of 787,000 shares. Cantor Fitzgerald raised its price target to $55 despite the drop. Investors await updates on late-stage epilepsy trial timelines and commercialization plans.
5 January 2026
··
1 … 811 812 813 814 815 … 1,891

Stock Market Today

  • SpaceX May Join S&P 500 Faster After Proposed Rule Changes Ahead of IPO
    May 2, 2026, 5:42 PM EDT. S&P Global Dow Jones Indices is considering rule changes that could allow Elon Musk's SpaceX to enter the S&P 500 index just six months after its IPO instead of the current 12 months. The proposed revisions include removing profitability requirements and minimum Investable Weight Factor for megacap companies, reflecting the rise of large firms without positive net income. SpaceX, planning a dual-class share IPO possibly on Nasdaq, could benefit from faster index inclusion amid these changes. Nasdaq is also easing entry rules for its 100-stock index. Investors remain cautious as SpaceX's ambitious projects face supply chain and technology risks ahead of its public debut.

Latest article

Citigroup Stock’s Big Week: Fitch Turns Positive, and Jane Fraser Gets One More Test

Citigroup Stock’s Big Week: Fitch Turns Positive, and Jane Fraser Gets One More Test

2 May 2026
Fitch Ratings revised its outlook on Citigroup to positive, affirming its issuer ratings at A and F1. Citi reported Q1 net income of $5.8 billion on $24.6 billion revenue, with a 13.1% return on tangible common equity. Shares closed Friday at $127.44, valuing the bank at $237.4 billion. Citi said it returned $7.4 billion to shareholders in Q1 through buybacks and dividends.
MP Materials Stock Faces Rare Earth Test as China Supply Signals Shift Before Earnings

MP Materials Stock Faces Rare Earth Test as China Supply Signals Shift Before Earnings

2 May 2026
MP Materials will report first-quarter earnings on May 7 after market close. China shipped 60 tons of yttrium oxide to the U.S. in March, but annual U.S. imports remain down 75% from a year earlier. MP shares ended Friday at $66.63, valuing the company at $11.7 billion. The firm recently began producing neodymium-iron-boron magnets at its Texas facility.
Realty Income Stock Back In Focus As Vanguard Stake Lands Before Q1 Earnings

Realty Income Stock Back In Focus As Vanguard Stake Lands Before Q1 Earnings

2 May 2026
Vanguard Capital Management disclosed a 7.49% stake in Realty Income Corp, holding nearly 69.9 million shares as of March 31, according to an SEC filing. Realty Income will report first-quarter results after the NYSE closes on May 6. Shares closed Friday at $63.81, down 0.67%. Vanguard said the holding is not for activist purposes.
Go toTop